IZINI
LIVE

Serial Number

99567562

Owner

Edge Eye Labs Inc.

Attorney

Andrew Pontious

Filing Date

Dec 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

IZINI Trademark

Serial Number: 99567562

IZINI is a trademark filed by Edge Eye Labs Inc. on December 27, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Edge Eye Labs Inc. (2 trademarks)

124 Lily Street
San Francisco, CA 94102

Entity Type: 03

Trademark Details

Filing Date

December 27, 2025

Registration Date

Not Registered

Goods & Services

Eyeglasses; Eyewear; Ophthalmic lenses; Optical lenses; Eyeglass lenses; Eyewear, namely, wearable electronic eyewear devices designed to assist patients with vision disorders; Eyewear, namely, wearable electronic eyewear devices designed to assist patients with amblyopia; Eyewear, namely, eyeglasses for treating amblyopia; Eyewear, namely, eyewear for treating amblyopia; Eyewear, namely, attachments to eyewear to treat amblyopia; Eyewear, namely, attachments to eyeglasses to treat amblyopia; Eyewear, namely, eyeglasses for vision training and correction; Eyewear, namely, eyewear for vision training and correction; Software as a Medical Device (SaMD), recorded, for diagnosing vision disorders; Software as a Medical Device (SaMD), recorded, for treating amblyopia; Software as a Medical Device (SaMD), recorded, for diagnosing amblyopia; Software as a Medical Device (SaMD), recorded, for treating vision disorders; Downloadable mobile applications for retrieving and displaying health information; Eyewear, namely, eyepatches; Eyewear, namely, eyepatches to assist patients with vision disorders; Eyewear, namely, eyepatches to assist patients with amblyopia; Eyewear, namely, eyepatches for vision training and correction; Downloadable scientific and medical data via the internet; Downloadable training materials in the field of vision disorders and treatment of vision disorders; Downloadable training materials in the field of evaluating and treating amblyopia; Downloadable mobile applications for vision training and correction; Recorded Software as a Medical Device (SaMD) for use as a medical instrument for diagnosing and treating vision disorders; Electronic communications systems comprised of computer hardware and recorded software for the transmission of data between two points; Recorded computer software using artificial intelligence (AI) for machine learning in the field of vision disorders and treatment of vision disorders; Recorded computer software using artificial intelligence (AI) for machine learning in the field of tracking and monitoring ocular activity; Recorded Software as a Medical Device (SaMD) for use as a medical instrument for tracking and monitoring ocular activity; Recorded computer software using artificial intelligence (AI) for machine learning in the field of treating vision disorders; Downloadable computer programs using artificial intelligence (AI) for machine learning in the field of treating vision disorders; Downloadable computer programs using artificial intelligence (AI) for machine learning in the field of tracking and monitoring ocular activity; Computer hardware and recorded software sold as a unit for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Downloadable dynamic databases in the field of vision disorders and treatment of vision disorders

Software as a service (SAAS) services featuring software for use in evaluating and treating vision disorders; Software as a service (SAAS) services featuring software for use in evaluating and treating amblyopia; Technical support services, namely, troubleshooting of computer software problems; Technical support services, namely, troubleshooting in the nature of diagnosing problems with medical equipment; Software as a service (SAAS) services featuring software for vision training; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Electronic data storage; Compiling data for research purposes in the field of medical science and medical consultancy; Medical research; Providing information about medical and scientific research via a website; Providing information about medical research; Medical and scientific research in the field of vision disorders and treatment of vision disorders; Providing information about medical research in the field of vision disorders and treatment of vision disorders; Providing medical and scientific research information; Medical research in the field of vision disorders and vision disorder treatments; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for machine learning in the field of vision disorders and treatment of vision disorders; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for machine learning in the field of vision disorders and treatment of vision disorders; Electronic storage of electronic media, namely, images, text and audio data; Electronic storage services for archiving databases, images and other electronic data; Temporary electronic storage of information and data; Computer services, namely, cloud hosting provider services; Cloud storage services for electronic data lakes; Cloud storage services for electronic files; Cloud storage services for electronic data; Software as a service (SAAS) services featuring software for collecting ocular activity and visual performance; Software as a service (SAAS) services featuring software for ocular activity and visual performance; Software as a service (SAAS) services featuring software for use in monitoring and tracking ocular activity and visual performance; Clinical research in the field of vision disorders and treatment of vision disorders; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for machine learning in the field of tracking and monitoring ocular activity and visual performance; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for machine learning in the field of tracking and monitoring ocular activity and visual performance

Medical devices for use in treating or diagnosing vision disorders and amblyopia with integrated recorded operating system software, sold as a unit; Medical devices for use in treating or diagnosing vision disorders; Medical devices for use in treating or diagnosing amblyopia; Medical devices for use in treating or diagnosing pediatric amblyopia; Non-invasive medical devices for use in treating amblyopia; Non-invasive medical devices for use in treating pediatric amblyopia; Sensors for medical use to be worn by a human to gather human biometric data and also including wearable sensors monitor and track ocular activity and visual performance sold as a unit; Medical instruments for measuring and displaying ocular activity and visual performance; Medical devices for use in treating or diagnosing amblyopia with integrated recorded software for monitoring and tracking ocular activity and visual performance, sold as a unit; Medical devices for use in treating or diagnosing vision disorders and impairment with integrated recorded software for monitoring and tracking ocular activity and visual performance, sold as a unit; Medical devices for use in treating or diagnosing vision disorders and impairment with integrated recorded software for vision training and correction, sold as a unit; Medical devices for use in treating or diagnosing amblyopia with integrated recorded software for vision training and correction, sold as a unit; Non-invasive medical devices for use in treating vision disorders

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 21, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 21, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 21, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 28, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Dec 27, 2025 MAFR
NEW APPLICATION ENTERED
Dec 27, 2025 NWAP